Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Stockbrügger

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1989
Antimuscarinic drugsR W Stockbrügger
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|April 20, 2000
Nonsteroidal anti-inflammatory drugs (NSAIDs) in the prevention of colorectal cancerR W Stockbrügger
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 1, 1996
Future directions in research of endogenous production on N-nitroso compoundsR W Stockbrügger
Pharmacology|January 1, 1988
Clinical significance of M1 receptor antagonistsR W Stockbrügger
Gut|December 1, 1987
Vagal control of gastric alkaline secretionR W Stockbrügger
Scandinavian Journal of Gastroenterology. Supplement|January 28, 2004
Screening for colorectal cancer: medical and economic aspectsS Sanduleanu, R W Stockbrügger
Zeitschrift Fur Gastroenterologie|July 1, 1989
[Possibilities for use and limits of the H2 breath test in gastroenterologic diagnosis]U Armbrecht, R W Stockbrügger
European Journal of Gastroenterology & Hepatology|December 17, 1998
Is appendectomy a causative factor in ulcerative colitis?M G Russel, R W Stockbrügger
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1995
Bacteria in the aetio-pathogenesis of gastric cancer: a reviewG M Houben, R W Stockbrügger
Digestive Diseases and Sciences|October 1, 1996
Effect of nizatidine 300 mg at night and omeprazole 20 mg in the morning on 24-hour intragastric pH and bacterial overgrowth in patients with acute duodenal ulcerR J Brummer, R W Stockbrügger
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1989
Antimuscarinic drugsR W Stockbrügger
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|April 20, 2000
Nonsteroidal anti-inflammatory drugs (NSAIDs) in the prevention of colorectal cancerR W Stockbrügger
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 1, 1996
Future directions in research of endogenous production on N-nitroso compoundsR W Stockbrügger
Pharmacology|January 1, 1988
Clinical significance of M1 receptor antagonistsR W Stockbrügger
Gut|December 1, 1987
Vagal control of gastric alkaline secretionR W Stockbrügger
Scandinavian Journal of Gastroenterology. Supplement|January 28, 2004
Screening for colorectal cancer: medical and economic aspectsS Sanduleanu, R W Stockbrügger
Zeitschrift Fur Gastroenterologie|July 1, 1989
[Possibilities for use and limits of the H2 breath test in gastroenterologic diagnosis]U Armbrecht, R W Stockbrügger
European Journal of Gastroenterology & Hepatology|December 17, 1998
Is appendectomy a causative factor in ulcerative colitis?M G Russel, R W Stockbrügger
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1995
Bacteria in the aetio-pathogenesis of gastric cancer: a reviewG M Houben, R W Stockbrügger
Digestive Diseases and Sciences|October 1, 1996
Effect of nizatidine 300 mg at night and omeprazole 20 mg in the morning on 24-hour intragastric pH and bacterial overgrowth in patients with acute duodenal ulcerR J Brummer, R W Stockbrügger
Pageof 13